| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/26/1995 | CA2174650A1 Piperidinyl camphorsulfonyl oxytocin antagonists |
| 05/26/1995 | CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/24/1995 | EP0654078A1 A thrombin blood fraction for use in a medical procedure |
| 05/24/1995 | EP0630275A4 Fibrin sealant delivery method. |
| 05/24/1995 | EP0447468B1 Ancrod proteins, their production and use |
| 05/24/1995 | EP0440709B1 Thrombolytic agents with modified kringle domains |
| 05/24/1995 | CN1028529C Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in treatment of thrombotic and vasospastic disease |
| 05/23/1995 | US5418233 For inhibiting cell aggregation |
| 05/23/1995 | CA1335666C Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii |
| 05/18/1995 | WO1995013385A2 Thrombin mutants |
| 05/18/1995 | WO1995013365A1 Generation of high titers of recombinant aav vectors |
| 05/18/1995 | WO1995013296A1 Receptor specific atrial natriuretic peptides |
| 05/18/1995 | WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 05/18/1995 | WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants |
| 05/18/1995 | WO1995013274A1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 05/18/1995 | WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
| 05/18/1995 | CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
| 05/18/1995 | CA2175897A1 6-oxo-nucleosides useful as immunosuppressants |
| 05/18/1995 | CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 05/17/1995 | EP0653434A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 05/17/1995 | EP0652900A1 Thrombin inhibitors |
| 05/17/1995 | EP0652897A1 Peptide inhibitors of selectin binding |
| 05/17/1995 | EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
| 05/17/1995 | EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 05/17/1995 | EP0652750A1 Use of alpha,omega-dicarboxylic acids as fibrinogen reducers |
| 05/17/1995 | CN1102640A Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis |
| 05/17/1995 | CA2135711A1 Cyclic amino acid derivatives |
| 05/16/1995 | US5416195 Polypeptide derivatives of granulocyte colony stimulating factor |
| 05/16/1995 | US5416117 Cyclopropenone derivatives |
| 05/16/1995 | US5416099 Fibrinogen receptor antagonists |
| 05/16/1995 | US5416006 Modification of plasminogen activators |
| 05/13/1995 | CA2135536A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 05/13/1995 | CA2134192A1 5, 6-bicyclic glycoprotein iib/iiia antagonists |
| 05/11/1995 | WO1995012674A1 Human kunitz-type protease inhibitors |
| 05/11/1995 | WO1995012592A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 05/11/1995 | WO1995012584A1 Novel benzoyl guanidines, their production and their use in medicaments |
| 05/11/1995 | WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications |
| 05/11/1995 | WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 05/11/1995 | WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | WO1995012412A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | DE4421686A1 Liposomes containing bioavailable iron(II) and process for their preparation |
| 05/11/1995 | CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2175838A1 Novel benzoyl guanidines, their production and their use in medicaments |
| 05/11/1995 | CA2175837A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 05/11/1995 | CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | CA2175214A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 05/10/1995 | EP0651769A1 Leukaemia inhibitory factor-binding protein |
| 05/10/1995 | EP0651766A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 05/10/1995 | EP0651743A1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 05/10/1995 | EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 05/10/1995 | EP0651648A1 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder |
| 05/10/1995 | CN1102438A Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
| 05/09/1995 | US5414088 2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compounds |
| 05/04/1995 | WO1995011987A1 Chimeric proteins including protease nexin-1 variants |
| 05/04/1995 | WO1995011966A1 Human activated protein c preparation and process for producing the same |
| 05/04/1995 | WO1995011698A1 Method of stabilizing protein c or activated protein c and stabilized composition |
| 05/04/1995 | WO1995011693A1 Hemoregulatory peptides |
| 05/04/1995 | WO1995011690A1 Desferrioxamine oral delivery system |
| 05/03/1995 | EP0651054A1 Virus-inactivated factor Xa preparation |
| 05/03/1995 | EP0650953A1 Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them |
| 05/03/1995 | EP0650364A1 Purification of factor ix |
| 05/03/1995 | EP0379522B1 Uses of recombinant colony stimulating factor-1 |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 04/29/1995 | CA2134536A1 Cyclized analogues of fatty acid, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/26/1995 | EP0649854A1 Bisconjugates comprising two saccharides and a spacer |
| 04/26/1995 | EP0649839A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 04/26/1995 | EP0649308A1 Prevention of hemolysis |
| 04/26/1995 | CN1101847A Process of preparing medicine for treating anemia and promoting leukoblastosis by rhodiola root extract |
| 04/25/1995 | US5410064 Thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase |
| 04/25/1995 | US5410022 Chromatic purification of a Factor VIII-containing fraction of blood, treating with a surfactant and freeze drying followed by heat treatment |
| 04/25/1995 | US5409990 Useful for replacement therapy in patient suffering from hemophilia B |
| 04/25/1995 | US5409959 Antithrombotic treatment with calix(n)arene compounds |
| 04/25/1995 | US5409912 Leustroducsin H, its preparation and its therapeutic use |
| 04/25/1995 | US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof |
| 04/25/1995 | US5409700 Pharmaceutical compositions comprising modified and unmodified plasminogen activators |
| 04/25/1995 | US5409699 Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity |
| 04/25/1995 | CA1335375C Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical composition containing them |
| 04/25/1995 | CA1335369C Process for the purification and pasteurization of urokinase |
| 04/23/1995 | CA2132883A1 1-amino-ethylindole-derivatives |
| 04/20/1995 | WO1995010295A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/19/1995 | EP0648780A1 Heterocyclic thrombin inhibitors |
| 04/19/1995 | EP0648741A1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents |
| 04/19/1995 | EP0648224A1 Conformationally restrained peptide analogs as antiplatelet agents |
| 04/19/1995 | EP0648209A1 Contrast agents for mr diagnosis |
| 04/19/1995 | EP0570375B1 Novel peptides with anticoagulatory effect |
| 04/19/1995 | EP0510036B1 2-substituted 4,5-diphenyl-imidazoles |
| 04/18/1995 | US5408039 Repeated ion exchanging of plasma cryoprecipitate, then affinity chromatography of effluent |
| 04/18/1995 | US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof |
| 04/18/1995 | US5407946 Pyrrolidine compounds which are useful as thromboxane AZ-inhibitors |